BioSpace News Archive

The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the third quarter of 2020 of $0.74 per share on outstanding common stock.

Blue Cross Blue Shield of Massachusetts (“Blue Cross”) has distributed its 50,000th meal as part of its Community Meal Program in partnership with Lovin’ Spoonfuls. The program, now in its 10th week, was created to address the risi

DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss second quarter results on Thursday, July 30, 2020, at 5:00 p.m. Eastern Time.

ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2020 on Wednesday, August 5, 2020, after the New York Stock Exchange closes.

Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, today announced that it has reached an agreement in principle with the Department of Justice (“DOJ”)

ISM® Introduces Hospital PMI™ and Renames Non-Manufacturing Index (NMI®) as Services PMI™

Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, announced its Spiration® Valve System won Silver in the Medical category of the 2020 Edison Awards™.

VALBIOTIS (Paris:ALVAL) (FR0013254851 - ALVAL, PEA/SME eligible) a Research & Development company committed to scientific innovation for preventing and combating metabolic diseases, announces the First Patient First Visit in the international Phase II/III REVERSE-IT clinical study designed to assess TOTUM-63 for the reduction of Type 2 Diabetes metabolic risk factors.

The New Facility Will Offer Convenient, Quick Access to Quality Emergency Room and Urgent Care in Hamilton County

CORPORATION TERRANUEVA (CSE : TEQ) (the “Corporation” or “Terranueva”) and Laboratoire LSL Inc. (“Laboratoire LSL”) announce that the parties have terminated their contractual relationship for the acquisition of the securities of Laboratoire LSL announced by press release on March 27, 2020.